Concortis Biosystems Corp

Concortis Biosystems Corp is a biotechnology company founded in 2011 with a focus on driving advanced biotherapeutics with enhanced efficacy and reduced side effects, particularly in the areas of oncology and metabolic diseases. Through their proprietary conjugation technologies and innovative drug delivery systems, Concortis integrates small molecule drugs with various biologics to improve treatment outcomes. With its headquarters in the United States, the company is at the forefront of developing groundbreaking solutions in the biotechnology, healthcare, and life sciences industries. As of now, there is no public information available regarding their latest investment or the involved investors.